Next Article in Journal
Epigenetic Regulation of Estrogen Receptor Genes’ Expressions in Adipose Tissue in the Course of Obesity
Next Article in Special Issue
Nitric Oxide, Nitric Oxide Formers and Their Physiological Impacts in Bacteria
Previous Article in Journal
Metformin Inhibits Lipid Droplets Fusion and Growth via Reduction in Cidec and Its Regulatory Factors in Rat Adipose-Derived Stem Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 11
10.3390/ijms23115987
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis

by
Dina K. Gaynullina
1,
Olga S. Tarasova
1,2,
Anastasia A. Shvetsova
1,
Anna A. Borzykh
1,2 and
Rudolf Schubert
3,*
1
Department of Human and Animal Physiology, Faculty of Biology, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia
2
Laboratory of Exercise Physiology, State Research Center of the Russian Federation-Institute for Biomedical Problems, Russian Academy of Sciences, 123007 Moscow, Russia
3
Physiology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, 86159 Augsburg, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(11), 5987; https://doi.org/10.3390/ijms23115987
Submission received: 25 April 2022 / Revised: 16 May 2022 / Accepted: 23 May 2022 / Published: 26 May 2022
(This article belongs to the Special Issue Nitric Oxide Synthases: Function and Regulation)
Browse Figure
Versions Notes

Abstract

:
The activity of many vasomotor signaling pathways strongly depends on extracellular/intracellular pH. Nitric oxide (NO) is one of the most important vasodilators produced by the endothelium. In this review, we present evidence that in most vascular beds of mature mammalian organisms metabolic or respiratory acidosis increases functional endothelial NO-synthase (eNOS) activity, despite the observation that direct effects of low pH on eNOS enzymatic activity are inhibitory. This can be explained by the fact that acidosis increases the activity of signaling pathways that positively regulate eNOS activity. The role of NO in the regulation of vascular tone is greater in early postnatal ontogenesis compared to adulthood. Importantly, in early postnatal ontogenesis acidosis also augments functional eNOS activity and its contribution to the regulation of arterial contractility. Therefore, the effect of acidosis on total peripheral resistance in neonates may be stronger than in adults and can be one of the reasons for an undesirable decrease in blood pressure during neonatal asphyxia. The latter, however, should be proven in future studies.

1. Acidosis Generally Reduces Tone of Arterial Vessels

The activity of many vasomotor signaling pathways strongly depends on pH. Therefore, intracellular pH is powerfully regulated by several membrane transporters, that remove excess acids or bases from the cell. In vascular cells, proton extrusion is accomplished mainly by Na+/HCO3− cotransport and Na+/H+-exchange mechanisms, and excess HCO3− is removed in exchange for Cl− [1,2].
A lowered pH—acidosis—can develop due to the accumulation of proton-donating metabolites in the extracellular fluid of intensively working organs such as contracting skeletal muscles or because of renal, gastrointestinal, and metabolic disorders (so-called metabolic acidosis). In addition, the accumulation of CO2 in the blood due to respiratory disorders causes hypercapnic (respiratory) acidosis. In the course of several minutes, changes in extracellular pH are transmitted into changes in intracellular pH, which have the same direction and are equal to about a half or more of the extracellular change [1,3]. Acidosis can considerably affect the functioning of many organs, both directly and through the alteration of their blood supply. In addition, in some cases acidosis is associated with oxidative stress [4], which can be a supplementary factor affecting vascular functioning [5,6,7,8].
In some studies, extracellular acidosis was shown to increase arterial tone, as in the aorta and coronary arteries [9,10,11,12]. However, the prevailing effect of acidosis is the opposite. Generally, acidosis decreases vascular reactivity to constrictor stimuli (exerts an anticonstrictor effect) and potentiates vasodilatory responses. Importantly, such effects of acidosis are clearly manifested in small arteries and arterioles, which regulate peripheral vascular resistance, and hence the level of arterial blood pressure. Acidosis has been shown to decrease contractile responses of resistance arteries of various organs, including intestinal arteries [13,14], cerebral arteries [15,16,17], retinal arteries [18], mammary arteries [19], and skeletal muscle arteries [20]. The effects of acidosis on vascular tone can be realized through various mechanisms affecting both smooth muscle and endothelial cells.
Relaxation of arterial smooth muscle cells is associated with a decrease in the intracellular Ca2+ concentration [15,18]. This is often due to the depression in voltage-operated L-type Ca2+-channel activity [2,21], the opening probability of which directly depends on extracellular pH [22]. Further, low intracellular pH causes vasorelaxation via activation of ATP-sensitive K+ (KATP) channels [23,24]. In addition, large-conductance Ca2+-activated K+-channels (BKCa-channels) demonstrate a dual response to acidification: they are directly inhibited by low intracellular pH [25] but can be activated by acidosis-potentiated Ca2+-signals from the sarcoplasmic reticulum (Ca2+-sparks), at least in cerebral arterioles [26]. An increase in potassium conductance hyperpolarizes the vascular smooth cell membrane, thereby providing an additional mechanism for the decrease in voltage-operated Ca2+-channel activity and Ca2+-influx from the extracellular space. Finally, long-term depression of vasocontractile responses by acidosis is associated with a decrease in the Ca2+-sensitivity of the smooth muscle cell contractile apparatus due to the suppression of Rho-kinase activity [27]. Of note, the maximum of Rho-kinase activity is achieved at pH 7.4 and activity markedly decreases at pH < 7.0 [27].
Endothelium-dependent relaxation of vascular smooth muscle can be mediated by nitric oxide (NO), prostacyclin, and endothelium-derived hyperpolarizing factor (EDHF), which is a combination of several molecular mechanisms [28]. It was demonstrated that acidosis can increase the activity of the NO-signaling pathway in the vascular wall [13,23,24,29]. A potentiating effect of acidosis was suggested for the EDHF-pathway as well [29]. Contrarily, the contribution of prostacyclin to endothelium-dependent vasorelaxation may be decreased by acidosis [29].
In this review, we will focus on the functional effects of acidosis on the NO-signaling pathway in the vasculature, based on the key role of NO in vascular physiology and pathophysiology. Importantly, the activity of the NO-signaling pathway in the systemic vasculature is a key mechanism for the protectively low blood pressure in the circulatory system at perinatal age [30]. Therefore, in the last section of this review, we discuss the effects of acidosis on eNOS functional activity during early postnatal ontogenesis.

2. NO as a Key Vasorelaxing Factor in the Vasculature

Endothelial NO-synthase (eNOS) is the enzyme that produces NO—a key vasorelaxatory substance derived from the endothelium [31]. eNOS activity in vascular endothelial cells is regulated in many ways. The enzymatic activity of eNOS depends on its substrate L-arginine, the availability of cofactors (tetrahydrobiopterin (BH4) is an essential cofactor), and can be suppressed by endogenous inhibitors, in particular asymmetrical dimethyl arginine (ADMA) [31]. A key regulatory mechanism that affects eNOS activity is its dependence on intracellular Ca2+, determined by the activity of endothelial ion channels and calcium transporters located in particular in the cell membrane and the membrane of the sarcoplasmic reticulum [32]. Furthermore, the functional state of eNOS is controlled by the degree of its modifications at the transcriptional, post-transcriptional, and post-translational levels (for example, phosphorylation, palmitoylation, S-glutathionylation, and S-nitrosylation) [33,34]. Similar modifications of proteins involved in the regulation of eNOS activity will also affect eNOS function, albeit indirectly. This, however, is beyond the scope of this review. In addition, eNOS can interact with various proteins that are able to change eNOS activity, (e.g., caveolin-1, heat shock protein 90 (HSP90), endoglin, nitric oxide synthase trafficking (NOSTRIN), nitric oxide synthase-interacting protein (NOSIP), etc.) [34,35]. A detailed discussion of the regulation of eNOS activity including enzyme modifications, as well as the interaction of eNOS with other proteins, has been the subject of many previous review articles (see, for example, [33,34,35,36,37]). Therefore, it is not the aim of the authors of the present review to provide a comprehensive overview of the available literature on the regulation of eNOS in general. We briefly discuss only the mechanisms regulating eNOS activity that can potentially be affected by extracellular acidosis.
The Ca2+/calmodulin complex is an indispensable regulatory factor of eNOS. Ca2+ entry into endothelial cells is provided by different types of transient receptor potential (TRP) channels as well as by the Piezo1 channel [32,38]. Of note, the TRPV1 channel was suggested to function not only as a Ca2+ channel but also as a scaffold for the recruitment and formation of a complex comprising eNOS and key regulatory kinases, thereby providing necessary protein–protein interactions for the appropriate activation of eNOS [39]. Further, a functional complex between the TRPV4 channel and eNOS was described as important for proper endothelial functioning and vasodilation [40]. In addition, the amplification of Ca2+ signaling in endothelial cells may occur via Piezo1/Pannexin1-mediated ATP release, where the latter activates purinergic receptors thereby augmenting Ca2+ entry [32,38,41].
In addition to its dependency on Ca2+, there is another well-known regulatory mechanism of eNOS, phosphorylation. Thus, eNOS can be phosphorylated at several serine (Ser), threonine (Thr), and tyrosine (Tyr) residues, representing activatory and inhibitory phosphorylation sites, whereby phosphorylation/dephosphorylation may dynamically modulate eNOS enzyme activity. These phosphorylation sites include Tyr81, Ser114, Thr495, Ser615, Ser633, Tyr657, and Ser1177 [33,42].
Ser1177. This phosphorylation site is considered as one of the main eNOS activation sites [33,42,43]. In cultured endothelial cells, the level of phosphorylation of Ser1177 rapidly increases under the influence of shear stress [44] and receptor agonists, such as bradykinin or vascular endothelial growth factor [45]. The main pathway responsible for such phosphorylation is the PI3/Akt -kinase pathway [44]. Phosphorylation of this site is also possible following the action of Ca2+/calmodulin-dependent kinase II (CaMKII) [45], protein kinase A (PKA) [46], protein kinase G (PKG) [42,47] or protein kinase N2 [48]. In addition, it was found that the activation of AMP-activated protein kinase in endothelial cells also leads to an increase in the level of eNOS phosphorylation at this site and, accordingly, the production of nitric oxide [49,50,51,52].
Ser615 and Ser633. The phosphorylation of these residues was shown to elevate eNOS activity and NO release [33,42,53,54]. The phosphorylation of Ser615 and Ser633 can be induced by Akt, PKA, AMPK, or Pim1 (proviral integration site for Moloney murine leukemia virus, serine/threonine kinase) [33,42,53,55,56,57]. In addition, Ser633 was shown to be phosphorylated by extracellular signal-regulated kinases ERK1/2 [58,59].
Thr495. Phosphorylation of this residue leads to a decrease in eNOS activity. The kinase that phosphorylates eNOS at Thr495 is claimed to be protein kinase C (PKC); PKC inhibitors considerably increase the synthesis of NO [45]. In addition, in cultured endothelial cells, this regulatory site was shown to be phosphorylated by Rho-kinase, since a Rho-kinase inhibitor reduced thrombin-induced eNOS phosphorylation at Thr495 [60].
Ser114. Controversial effects on eNOS enzymatic activity (activation in some studies, inhibition in others) were reported when eNOS was phosphorylated at this site (reviewed in [42]). Accordingly, the exact mechanisms and kinases responsible for this phosphorylation are not yet fully understood [42].
The role of tyrosine phosphorylation of eNOS seems to be less studied. Src kinase and Abelson tyrosine protein kinase (ABL)1 were shown to phosphorylate eNOS at Tyr81 and increase its enzymatic activity [33,42,61,62]. In contrast, phosphorylation at Tyr657 was shown to be mediated by proline-rich tyrosine kinase 2 (PYK2) and to decrease eNOS enzymatic activity [33,42,63,64,65].
Of note, the regulation of eNOS activity may also occur by phosphatases, in particular by vascular endothelial protein tyrosine phosphatase (VE-PTP), which demonstrates highly selective expression in endothelial cells [66]. VE-PTP can dephosphorylate eNOS at Tyr81 thereby decreasing its enzymatic activity [62,67]. Accordingly, VE-PTP inhibition increased the phosphorylation of eNOS at Tyr81 and NO production [62,67].
Thus, eNOS activity in endothelial cells can be dynamically regulated by phosphorylation/dephosphorylation under the action of various kinases, which provides fine-tuning of nitric oxide synthesis and, accordingly, its physiological effects on the cardiovascular system.
NO derived from endothelial cells diffuses into smooth muscle cells, which leads to vasorelaxation. The key acceptor of NO in smooth muscle is soluble guanylate cyclase, which produces cyclic guanosine monophosphate (cGMP) from guanosine-5’-triphosphate (GTP). cGMP activates PKG, which phosphorylates serine and threonine residues of a variety of targets in smooth muscle cells. The list of PKG targets in smooth muscle cells includes proteins involved in the regulation of the cytoplasmic Ca2+ concentration and the Ca2+-dependence of smooth muscle contraction.
One of the main targets of PKG is the BKCa channel, which is activated by PKG-dependent phosphorylation [68,69,70]. This results in hyperpolarization of smooth muscle cells, subsequent deactivation of voltage-gated calcium channels, and, accordingly, a decrease in Ca2+ entry into the cell. In addition, PKG can induce hyperpolarization by phosphorylation of other types of potassium channels in smooth muscle cells [71]. Further, PKG is able to phosphorylate phospholamban, leading to an increase in the activity of Ca2+-ATPase (SERCA 2A) and, consequently, to a decrease in the cytoplasmic Ca2+ concentration [72]. Moreover, PKG can phosphorylate IRAG proteins, a PKG substrate associated with receptors for inositol trisphosphate (Inositol trisphosphate receptor-associated cGMP-kinase substrate). IRAG is constitutively associated with PKG and inositol trisphosphate receptors in the sarcoplasmic membrane. Upon activation, PKG phosphorylates IRAG, which leads to suppression of Ca2+ release from the reticulum [72].
In addition to influencing the Ca2+ homeostasis of smooth muscle cells, PKG regulates the Ca2+ sensitivity of their contractile apparatus. PKG is able to phosphorylate and inactivate the RhoA protein thereby leading to a decrease in procontractile Rho-kinase activity. Second, PKG can phosphorylate the regulatory subunit of myosin light chain phosphatase at the Ser695 site, thereby increasing the activity of the phosphatase. In parallel with an increase in the level of phosphorylation at the Ser695 residue, there is a decrease in the level of phosphorylation at the inactivation site of Thr696 [73] which removes a block from the activity of myosin light chain phosphatase.
Thus, the overall relaxatory effect of NO in vascular tissue would depend not only on the level of NO production by the endothelium but also on the smooth muscle cell sensitivity to NO, which is determined by the expression level/activity of different proteins in the NO-signaling cascade in smooth muscle cells.

3. Acidosis Increases eNOS Functional Activity and Expression in Arteries

Effects of acidosis on eNOS were studied at different levels, including short-term effects on eNOS functional activity and long-term effects on eNOS gene expression.

3.1. Metabolic Acidosis

Metabolic acidosis induced by an extracellular pH decrease to 7.0 or 6.5 strongly potentiated NO synthesis in isolated aortic endothelial cells loaded with the DAF-FM fluorescent dye [24]. Further, extracellular acidification to 6.5 was shown to increase intracellular NO concentration in endothelial and smooth muscle cells in rat aorta [74].
Accordingly, metabolic acidosis increased eNOS functional activity in several studies on isolated arteries. Extracellular acidification to pH 7.0 enhanced the endothelium-dependent relaxation of the isolated aorta to acetylcholine [75]. In another study on rat aorta, extracellular acidosis-induced relaxation was considerably reduced by a NO-synthase inhibitor [24]. The vasorelaxing effect of metabolic acidosis can be associated at least in part with an augmented NO-sensitivity of smooth muscle cells, judged by an augmented cGMP content in aortic smooth muscle cells and larger responses of the endothelium-denuded aorta to NO-donors [75].
In the isolated rat mesenteric artery acidification of the external solution to pH 6.6 led to the reduction of contractile responses to electrical field stimulation of intramural sympathetic nerves as well as to exogenous noradrenaline [13]. These effects of acidosis were diminished in the presence of NO-synthase inhibitors in the case of nerve stimulation and abolished in the case of noradrenaline-induced contraction [13]. In another study, extracellular acidosis (pH 6.8) enhanced acetylcholine-induced relaxations of mesenteric arteries [29]. This increase in endothelium-dependent relaxation was mediated by the NO-signaling pathway [29]. Further, acidosis increased the level of NO metabolites (NOx) as well as the cGMP level in the aortic wall [29].
In rat middle cerebral arteries a stepwise decrease in the pH of the external solution from 7.4 to 6.0 also induced relaxatory responses [23]. After inhibition of NO-synthase, only responses to the lowest pH value were observed, while responses to moderate acidification were completely suppressed [23].
Acute metabolic acidosis in vivo (blood pH 7.2) was accompanied by a more prominent drop of mean arterial pressure to acetylcholine infusion compared to animals with a normal blood pH level [76]. Importantly, acute metabolic acidosis led to an increase in plasma NO metabolite levels, pointing to a higher NO production under acidic conditions in vivo [76].

3.2. Hypercapnic (Respiratory) Acidosis

Hypercapnic (respiratory) acidosis, like metabolic acidosis, may also be associated with an increased effect of NO on vascular tone. Several studies proved such an influence in the coronary vascular bed. Acute hypercapnia lasting 10 min induced by an increase in pCO2 from 38.6 mmHg to 61.4 mmHg (pH shift from 7.38 to 7.12) augmented coronary blood flow in isolated perfused mouse hearts; this effect was almost completely abolished in the presence of a NOS-inhibitor [77]. Qualitatively similar results were obtained in experiments with blood perfusion of the heart in anesthetized, open-chest dogs [78]. In this study, NOS inhibitors greatly suppressed dilatory responses of the coronary vasculature induced by hypercapnic acidosis (10% CO2, pH 7.16) and acetylcholine. In addition, endothelium-independent dilator responses of the coronary vasculature to sodium nitroprusside were resistant to NOS inhibitors, pointing to a larger effect of acidosis on the endothelium compared to its effect on the smooth muscle in the coronary vascular bed.
Further, the hypercapnia-induced increase in cerebral blood flow in rats was greatly reduced by a NOS inhibitor [79,80]. Accordingly, the relaxation responses to hypercapnic acidosis (10–15% CO2) were considerably reduced by inhibition of NO synthesis in rat small cerebral arteries: the basilar artery [81] and a branch of the middle cerebral artery [3]. The anticontractile effect of acidosis was almost three times smaller in the presence of a NOS inhibitor [3]. Along with that, blockade of NO-synthesis did not change the relaxatory responses to hypercapnic acidosis in experiments on isolated canine and monkey basilar and middle cerebral arteries [82]. Moreover, inhibition of NO synthesis blunted the effects of hypercapnic acidosis on blood flow in the human ocular artery [83] but not on the relaxatory responses of isolated porcine retinal arterioles [18]. Thus, the mechanisms of hypercapnic acidosis vary by animal species or by the experimental approach used. The reason for this is not yet clear.

3.3. Long-Term Effects of Acidosis on the eNOS Expression Level

Long-term effects of acidosis on the eNOS expression level were also observed, in addition to its acute effects on functional eNOS activity. Hypercapnic acidosis lasting 8 h augmented cerebral blood flow in anesthetized pigs. This effect was considerably reduced by treatment with a NO-synthase inhibitor [84]. In addition, hypercapnia caused an increase in cerebrovascular nitrite production associated with a rise in the brain eNOS mRNA expression level as well as an increase in NO-dependent vasorelaxant responses to substance P [84]. Similarly, increased levels of eNOS mRNA and protein were observed in the swine retina after 6–8-h long hypercapnia. This was associated with increases in retinal blood flow and NO metabolite production, both alterations were prevented by the administration of a NOS inhibitor [85]. The available data reporting long-term effects of metabolic acidosis on eNOS expression are controversial. On the one hand, metabolic acidosis induced by HCl infusion lasting 4 h caused a reduction in eNOS protein content in the lungs [86]. On the other hand, HCl-induced extracellular acidosis caused an increase in eNOS mRNA and eNOS protein content in human pulmonary arterial endothelial cells after 90 and 180 min, respectively [87].
Therefore, these data indicate that long-lasting acidosis not only affects eNOS activity but additionally it can change the expression of eNOS. This complex interplay between changes in eNOS activity and eNOS expression may result in different scenarios, either a synergistic effect when, e.g., eNOS activity and expression increase or an antagonistic effect when, e.g., eNOS activity increases and eNOS expression decreases. Due to the paucity of published data on this topic, it is unclear at this time whether there is a predominant scenario for most vessels or whether the scenarios depend on circumstances, e.g., the vessel bed affected. Further studies are required to get a deeper understanding of the long-term effects of acidosis on the functional impact of eNOS.

4. Effects of Acidosis on Mechanisms Controlling eNOS Activity

The data described above demonstrate that in many vascular beds acute extracellular acidosis-induced vasorelaxation is associated with increased eNOS functional activity. At the same time, direct in vitro measurements of eNOS activity indicate that acidosis causes a decrease in eNOS activity [87,88]. eNOS activity deduced from the conversion rate of L-[14C]arginine to L-[14C]citrulline in tissue homogenates or cell extracts was considerably reduced with acidification. Maximum activity of eNOS was observed at the physiologically relevant pH of 7.4 and activity was markedly decreased at pH values below 7.0 [87,88].
The apparent contradiction between the effects of acidosis on functional eNOS activity in intact cells, on the one hand, and on its enzymatic activity in homogenates, on the other hand, can be explained by the fact that intracellular Ca2+ and signaling pathways that regulate eNOS activity in intact cells are also dependent on pH [31,37].
Both metabolic and hypercapnic acidosis was shown to increase the intracellular Ca2+ concentration in cultured rat aortic endothelial cells [89]. Similarly, an increase in cytosolic Ca2+ was observed in human pulmonary artery endothelial cells under conditions of hypercapnic acidosis [90]. Moreover, intracellular acidification induced by Na+/H+-exchange inhibitors was accompanied by an increase in cytosolic Ca2+ in bovine aortic endothelial cells [91].
The TRPV4 channel is considered one of the channel types providing Ca2+ entry into endothelial cells and activation of eNOS [32,92,93]. Importantly, TRPV4 channel opening probability may increase in acidosis [94], thereby providing beneficial conditions for eNOS activation. Further, the current carried by another member of the TRP channel family, the TRPV1 channel, which is also implicated in Ca2+ entry into endothelial cells [32,39], increases under acidic conditions. Along with that, an increase in the intracellular Ca2+ concentration was still present in acidified endothelial cells after the removal of Ca2+ from the extracellular solution, pointing to the potentiating effect of acidosis on the release of Ca2+ from intracellular stores [89,90,91].
Importantly, acidosis was shown to affect the activity of kinases regulating eNOS functioning. Activation of signaling pathways involving CaMKIIα, PKA, and PI3/Akt-kinase under acidic conditions was previously reported in hippocampal slice culture [95]. For cardiovascular tissues, known effects of acidosis are limited to the PI3/Akt-kinase signaling pathway. In the densely vascularized myocardium, hypercapnic acidosis (20% CO2, pH 6.9) for the first 3 min of reperfusion after a 30-min long coronary occlusion reduced myocardial ischemia/reperfusion injury due to activation of the PI3/Akt/eNOS signaling pathway [96]. Such transient acidosis was associated with higher levels of Akt phosphorylation and, importantly, higher NO release from perfused hearts. All effects of acidosis were suppressed by wortmannin, a PI3-kinase inhibitor. Therefore, Akt activity may be increased in acidified coronary endothelial cells, and subsequently, the phosphorylation of eNOS at Ser1177, Ser633, and Ser615 and therefore eNOS activity should rise in acidosis. This assumption should be proven experimentally in future studies.
Contrarily, enzymatic and functional activities of Rho-kinase were shown to decrease during acidification in the vascular wall [27]. Therefore, the reduction of eNOS phosphorylation at the inhibitory site Thr495 might lead to an increase in eNOS functional activity in acidosis. On the other hand, currently known effects of acidosis on PKC activity are limited to non-vascular tissues, which complicates the analysis of its vasomotor effects in acidosis. An increased phosphorylation level and, presumably, the activity of PKC were observed in acidified intestinal mucosal cells [97]. In addition, PKC activated by acidosis was shown to increase the activity of Na+/H+-exchange in renal brush border membranes [98], which is favorable for the restoration of normal pH levels. However, the question about a PKC-dependent inhibition of eNOS in acidified endothelial cells remains open.
Thus, acidosis can affect the activity of several mechanisms, which would result in higher levels of eNOS functional activity. This may include increased Ca2+ entry into endothelial cells and Ca2+ release from intracellular stores, augmented phosphorylation of the activator sites via PI3/Akt-kinase, and reduced phosphorylation at the inhibitory site Thr495 via Rho-kinase. Presumably, acidosis-induced changes in these regulatory pathways may surpass the direct inhibitory effect of acidosis on eNOS enzymatic activity.

5. NO-Dependent Regulation of Vascular Tone in Early Ontogenesis

The early postnatal period of life in mammals is associated with intensive growth and development of many organs and tissues. This is also true for the vasculature, which undergoes remarkable structural and functional remodeling during the early postnatal period. At the systemic level, the cardiovascular system in early ontogenesis is characterized by a level of blood pressure that is almost two times lower than in an adult organism [99,100]. In addition, the distribution of cardiac output among organs is different in early postnatal ontogenesis compared to the adult organism [101]. For example, such organs as the skin and the gastrointestinal tract receive a large proportion of cardiac output in neonates and this proportion decreases considerably with maturation [101]. This is achieved by alterations in the mechanisms regulating vascular tone during early postnatal development.
Importantly, the NO-dependent mechanism of vascular tone regulation demonstrates high activity in neonates. For example, in the early postnatal period, many vascular regions of the systemic circulation possess a greater anticontractile influence of NO compared to the adult organism [30,102,103,104]. This is evident from a prominent augmenting effect of NOS inhibitors on arterial contractile responses at perinatal age compared to small effects of the inhibitors in adulthood [104,105]. The greater anticontractile influence of NO in early postnatal ontogenesis is associated with a higher eNOS expression [105,106]. In addition, the activity of the PI3/Akt/eNOS signaling pathway in the vascular endothelium may be increased in neonates which can provide a high functional activity of eNOS at this stage of postnatal development [105]. Accordingly, the activity of the NO/sGC/PKG pathway in arterial smooth muscle is also higher at perinatal age [105].
At the systemic level, a greater impact of endothelium-derived NO on the control of the circulatory system during early postnatal development is manifested in higher pressor responses to the NOS inhibitor L-NAME and higher blood content of NO metabolites compared to the adult organism [104,105,107]. Therefore, the anticontractile effect of NO can be an important mechanism responsible for maintaining the low blood pressure level in the immature circulatory system.

6. During Early Postnatal Development, Acidosis Reduces Systemic Blood Pressure Potentially Due to an Increase in eNOS Activity in the Arterial System

Of note, the data on the vascular effects of acidosis presented above were obtained on adult mature individuals, while the ontogenetic aspect of eNOS functioning under acidic conditions remained outside the research scope. Nevertheless, understanding the effects of pH on the regulation of vascular tone is important not only for an adult organism but also for an organism in the period of antenatal and early postnatal ontogenesis. Acidosis can occur in newborns due to neonatal hypoxia (asphyxia), which, unfortunately, often occurs during childbirth [108,109]. According to the World Health Organization reports, neonatal asphyxia is one of the most common causes of death among infants (about 30–35% of neonatal deaths) and its incidence varies by region, level of care, and other factors [110,111]. Severe acidosis (blood pH less than 7.0) in neonates is associated with a prominent blood pressure drop [111] but the role of NO in this response has not been explored, to the best of our knowledge. Notably, vasorelaxation in response to acidosis was shown to be greater in the newborn than in the adult rabbit aorta [112] and resistance mesenteric arteries [113].
To address the question of how acidosis in neonates affects the functional contribution of eNOS to the regulation of vascular tone, we conducted an experimental series to study the effect of metabolic acidosis (pH 6.8) on the anticontractile influence of NO in skin feed arteries (saphenous artery) of 10–15-day-old rat pups. Importantly, cutaneous blood flow accounts for up to 20% of cardiac output in rats during the first weeks of life [101] and, therefore, constriction or dilation of skin arteries can prominently affect the level of systemic blood pressure. The contribution of NO to the regulation of the cutaneous circulation is large in the early postnatal period and decreases with maturation [30,105]. Vasomotor responses of saphenous arteries were studied under in vitro conditions (for details on the research methods, see the Supplementary Materials). At pH 6.8 the contractile responses of saphenous arteries of 10–15-day-old rat pups to the α1-adrenoceptor agonist methoxamine were reduced compared to pH 7.4 (Figure 1a, black solid line vs. black dotted line). The NO-synthase inhibitor L-NNA augmented contractile responses to methoxamine both at pH 7.4 and at pH 6.8 (Figure 1a, pH 7.4: black dotted line vs. red dotted line; pH 6.8: black solid line vs. the red solid line). Therefore, NO exhibits its anticontractile influence both at normal pH and under acidic conditions. Notably, the reduction in the contractile responses to methoxamine induced by a change of pH from 7.4 to 6.8 in the absence of L-NNA (see the large distance between two black lines) was not observed when the same change in pH was performed in the presence of the NO-synthase inhibitor L-NNA (two red lines lie close to each other). In addition, the contractile effect of L-NNA was greater at pH = 6.8 compared to pH = 7.4 (Figure 1b). Therefore, the anticontractile influence of NO was increased by acidosis in 10–15-day old rat pups.
Thus, our data demonstrate that acidosis increases eNOS functional activity in arteries during early postnatal development, similar to its effect in the adult organism. Since the functional contribution of eNOS to the regulation of vascular tone during early postnatal ontogenesis is higher than in adulthood [30], the final effect of acidosis on total peripheral resistance in neonates may be stronger than in adults. The latter, however, should be proven in future studies. Of note, taking into account that acidosis often occurs during hypoxia in childbirth or during asphyxia [108], it can be assumed that this, among other things, will cause an increase in eNOS functional activity. Ultimately, this can lead to a decrease in peripheral resistance and hence blood pressure in infants. This response, in turn, may create additional health risks for neonates. In addition, acidosis-induced changes in eNOS functional activity, especially when accompanied by long-term alterations in eNOS expression as described in Section 3.3, may have ultra long-term effects appearing in adulthood. However, no studies are currently available addressing the question of whether acidosis-induced changes in eNOS functional activity are only temporary, reversible effects or may persist in adulthood (acidosis memory). Importantly, in the adult organism even more complexity is added by the fact that the direct effect of acidosis on vascular tone can be opposed by vasoconstriction resulting from activation of the chemoreflex [114,115]. In neonates, this compensation is limited by underdeveloped sympathetic control of the cardiovascular system [116,117]. Thus, further studies are required to get insight into possible consequences for an adult life of acidosis-induced changes in eNOS functional activity induced in the early postnatal period.

7. Conclusions

To conclude, published studies mostly indicate that the functional activity of the NO-pathway increases under acidic conditions, despite the direct effects of acidosis on eNOS enzymatic activity being rather inhibitory. This is possibly due to changes in signaling pathways regulating eNOS activity in endothelial cells. For example, acidosis may increase Ca2+ entry into endothelial cells through different types of TRP channels, induce Ca2+ release from intracellular stores, augment phosphorylation of the eNOS activator sites via PI3/Akt-kinase and reduce phosphorylation at the inhibitory site Thr495 via Rho-kinase. Importantly, acidosis potentiates the functional contribution of eNOS to the anticontractile impact of NO on vascular tone not only in adulthood but in the early postnatal period as well. Therefore, in conditions of neonatal asphyxia and acidosis, the NO influence might be one of the mechanisms causing an undesirable decrease in blood pressure in infants. Further detailed studies are needed to elucidate the systemic effects of acidosis on eNOS functional activity in the early postnatal period, considering the high incidence of acidosis in infants as well as possible long-term consequences for adult life.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms23115987/s1. Reference [118] are cited in the Supplementary Materials.

Author Contributions

Conceptualization, D.K.G. and R.S.; investigation, D.K.G., A.A.S. and A.A.B.; writing—original draft preparation D.K.G., O.S.T. and R.S. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Russian Science Foundation (grant N 21-75-10036 for D.K.G., A.A.S. and A.A.B.).

Institutional Review Board Statement

All animal procedures were approved by the Bioethics Committee of Lomonosov Moscow State University (protocol 97-g-2, approval date 22 October 2021).

Informed Consent Statement

Not applicable.

Data Availability Statement

All data generated during this study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Boedtkjer, E.; Aalkjaer, C. Intracellular pH in the resistance vasculature: Regulation and functional implications. J. Vasc. Res. 2012, 49, 479–496. [Google Scholar] [CrossRef] [PubMed]
  2. Boedtkjer, E. Acid–base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone. J. Cereb. Blood Flow Metab. 2018, 38, 588–602. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Tian, K.; Vogel, P.; Lassen, N.A.; Mulvany, M.J.; Andreasen, F.; Aalkjær, C. Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries. Circ. Res. 1995, 76, 269–275. [Google Scholar] [CrossRef] [PubMed]
  4. Frassetto, L.A.; Sebastian, A. How metabolic acidosis and oxidative stress alone and interacting may increase the risk of fracture in diabetic subjects. Med. Hypotheses 2012, 79, 189–192. [Google Scholar] [CrossRef]
  5. Mateuszuk, Ł.; Campagna, R.; Kutryb-Zając, B.; Kuś, K.; Słominska, E.M.; Smolenski, R.T.; Chlopicki, S. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Biochem. Pharmacol. 2020, 178, 114019. [Google Scholar] [CrossRef]
  6. Campagna, R.; Mateuszuk, Ł.; Wojnar-Lason, K.; Kaczara, P.; Tworzydło, A.; Kij, A.; Bujok, R.; Mlynarski, J.; Wang, Y.; Sartini, D.; et al. Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury. Biochim. Biophys. Acta—Mol. Cell Res. 2021, 1868, 119082. [Google Scholar] [CrossRef]
  7. Szczesny-Malysiak, E.; Stojak, M.; Campagna, R.; Grosicki, M.; Jamrozik, M.; Kaczara, P.; Chlopicki, S. Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium. Oxidative Med. Cell. Longev. 2020, 2020, 4678252. [Google Scholar] [CrossRef]
  8. Aldosari, S.; Awad, M.; Harrington, E.O.; Sellke, F.W.; Abid, M.R. Subcellular reactive oxygen species (ROS) in cardiovascular pathophysiology. Antioxidants 2018, 7, 14. [Google Scholar] [CrossRef] [Green Version]
  9. Rohra, D.K.; Saito, S.Y.; Ohizumi, Y. Mechanism of acidic pH-induced contraction in spontaneously hypertensive rat aorta: Role of Ca2+ release from the sarcoplasmic reticulum. Acta Physiol. Scand. 2003, 179, 273–280. [Google Scholar] [CrossRef]
  10. Ma, Z.; Qi, J.; Fu, Z.; Ling, M.; Li, L.; Zhang, Y. Protective Role of Acidic pH-Activated Chloride Channel in Severe Acidosis-Induced Contraction from the Aorta of Spontaneously Hypertensive Rats. PLoS ONE 2013, 8, e61018. [Google Scholar] [CrossRef] [Green Version]
  11. Baxter, K.A.; Laher, I.; Church, J.; Hsiang, Y.N. Acidosis augments myogenic constriction in rat coronary arteries. Ann. Vasc. Surg. 2006, 20, 630–637. [Google Scholar] [CrossRef] [PubMed]
  12. Niu, L.; Liu, Y.; Hou, X.; Cui, L.; Li, J.; Zhang, X.; Zhang, M. Extracellular acidosis contracts coronary but neither renal nor mesenteric artery via modulation of H+,K+-ATPase, voltage-gated K+ channels and L-type Ca2+ channels. Exp. Physiol. 2014, 99, 995–1006. [Google Scholar] [CrossRef] [PubMed]
  13. Yartsev, V.N.; Karachentseva, O.V.; Dvoretsky, D.P. Effect of pH changes on reactivity of rat mesenteric artery segments at different magnitude of stretch. Acta Physiol. Scand. 2002, 174, 1–7. [Google Scholar] [CrossRef] [PubMed]
  14. Mohanty, I.; Suklabaidya, S.; Parija, S.C. Acidosis reduces the function and expression of α1D-adrenoceptor in superior mesenteric artery of capra hircus. Int. J. Pharmacol. 2016, 48, 399–406. [Google Scholar] [CrossRef] [Green Version]
  15. Aoyama, Y.; Ueda, K.; Setogawa, A.; Kawai, Y. Effects of pH on contraction and Ca2+ mobilization in vascular smooth muscles of the rabbit basilar artery. Jpn. J. Physiol. 1999, 49, 55–62. [Google Scholar] [CrossRef] [PubMed]
  16. Akanji, O.; Weinzierl, N.; Schubert, R.; Schilling, L. Acid sensing ion channels in rat cerebral arteries: Probing the expression pattern and vasomotor activity. Life Sci. 2019, 227, 193–200. [Google Scholar] [CrossRef]
  17. Aleksandrowicz, M.; Kozniewska, E. Compromised regulation of the rat brain parenchymal arterioles in vasopressin-associated acute hyponatremia. Microcirculation 2020, 27, e12644. [Google Scholar] [CrossRef]
  18. Hessellund, A.; Aalkjaer, C.; Bek, T. Effect of acidosis on isolated porcine retinal vessels. Curr. Eye Res. 2006, 31, 427–434. [Google Scholar] [CrossRef]
  19. Rohra, D.K.; Sharif, H.M.; Zubairi, H.S.; Sarfraz, K.; Ghayur, M.N.; Gilani, A.H. Acidosis-induced relaxation of human internal mammary artery is due to activation of ATP-sensitive potassium channels. Eur. J. Pharmacol. 2005, 514, 175–181. [Google Scholar] [CrossRef]
  20. Ives, S.J.; Andtbacka, R.H.I.; Noyes, R.D.; Morgan, R.G.; Gifford, J.R.; Park, S.Y.; Symons, J.D.; Richardson, R.S. α1-Adrenergic responsiveness in human skeletal muscle feed arteries: The impact of reducing extracellular pH. Exp. Physiol. 2013, 98, 256–267. [Google Scholar] [CrossRef] [Green Version]
  21. West, G.A.; Leppla, D.C.; Simard, J.M. Effects of external pH on ionic currents in smooth muscle cells from the basilar artery of the guinea pig. Circ. Res. 1992, 71, 201–209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Klöckner, U.; Isenberg, G. Calcium channel current of vascular smooth muscle cells: Extracellular protons modulate gating and single channel conductance. J. Gen. Physiol. 1994, 103, 665–678. [Google Scholar] [CrossRef] [Green Version]
  23. Lindauer, U.; Vogt, J.; Schuh-Hofer, S.; Dreier, J.P.; Dirnagl, U. Cerebrovascular Vasodilation to Extraluminal Acidosis Occurs via Combined Activation of ATP-Sensitive and Ca2+-Activated Potassium Channels. J. Cereb. Blood Flow Metab. 2003, 23, 1227–1238. [Google Scholar] [CrossRef] [Green Version]
  24. Celotto, A.C.; Restini, C.B.A.; Capellini, V.K.; Bendhack, L.M.; Evora, P.R.B. Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta. Eur. J. Pharmacol. 2011, 656, 88–93. [Google Scholar] [CrossRef] [PubMed]
  25. Schubert, R.; Krien, U.; Gagov, H. Protons inhibit the BKCa channel of rat small artery smooth muscle cells. J. Vasc. Res. 2001, 38, 30–38. [Google Scholar] [CrossRef] [PubMed]
  26. Dabertrand, F.; Nelson, M.T.; Brayden, J.E. Acidosis dilates brain parenchymal arterioles by conversion of calcium waves to sparks to activate BK channels. Circ. Res. 2012, 110, 285–294. [Google Scholar] [CrossRef] [Green Version]
  27. Boedtkjer, E.; Praetorius, J.; Matchkov, V.V.; Stankevicius, E.; Mogensen, S.; Füchtbauer, A.C.; Simonsen, U.; Füchtbauer, E.M.; Aalkjaer, C. Disruption of NA+,HCO3- cotransporter NBCn1 (slc4a7) Inhibits no-mediated vasorelaxation, smooth muscle Ca2+ Sensitivity, and hypertension development in mice. Circulation 2011, 124, 1819–1829. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Garland, C.J.; Dora, K.A. EDH: Endothelium-dependent hyperpolarization and microvascular signalling. Acta Physiol. 2017, 219, 152–161. [Google Scholar] [CrossRef] [Green Version]
  29. Mohanty, I.; Parija, S.C.; Suklabaidya, S.; Rattan, S. Acidosis potentiates endothelium-dependent vasorelaxation and gap junction communication in the superior mesenteric artery. Eur. J. Pharmacol. 2018, 827, 22–31. [Google Scholar] [CrossRef]
  30. Gaynullina, D.K.; Schubert, R.; Tarasova, O.S. Changes in endothelial nitric oxide production in systemic vessels during early ontogenesis—A key mechanism for the perinatal adaptation of the circulatory system. Int. J. Mol. Sci. 2019, 20, 1421. [Google Scholar] [CrossRef] [Green Version]
  31. Vanhoutte, P.M.; Zhao, Y.; Xu, A.; Leung, S.W.S. Thirty years of saying NO: Sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ. Res. 2016, 119, 375–396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Jackson, W.F. Endothelial Ion Channels and Cell-Cell Communication in the Microcirculation. Front. Physiol. 2022, 13, 805149. [Google Scholar] [CrossRef]
  33. Siragusa, M.; Fleming, I. The eNOS signalosome and its link to endothelial dysfunction. Pflug. Arch. Eur. J. Physiol. 2016, 468, 1125–1137. [Google Scholar] [CrossRef] [PubMed]
  34. Garcia, V.; Sessa, W.C. Endothelial NOS: Perspective and recent developments. Br. J. Pharmacol. 2019, 176, 189–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Mutchler, S.M.; Straub, A.C. Compartmentalized nitric oxide signaling in the resistance vasculature. Nitric Oxide 2015, 49, 8–15. [Google Scholar] [CrossRef] [Green Version]
  36. Su, Y. Regulation of Endothelial Nitric Oxide Synthase Activity by Protein-Protein Interaction. Curr. Pharm. Des. 2014, 20, 3514–3520. [Google Scholar] [CrossRef]
  37. Fleming, I. Molecular mechanisms underlying the activation of eNOS. Pflug. Arch. Eur. J. Physiol. 2010, 459, 793–806. [Google Scholar] [CrossRef]
  38. Wang, S.; Chennupati, R.; Kaur, H.; Iring, A.; Wettschureck, N.; Offermanns, S. Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J. Clin. Investig. 2016, 126, 4527–4536. [Google Scholar] [CrossRef]
  39. Ching, L.-C.; Kou, Y.R.; Shyue, S.-K.; Su, K.-H.; Wei, J.; Cheng, L.-C.; Yu, Y.-B.; Pan, C.-C.; Lee, T.-S. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc. Res. 2011, 91, 492–501. [Google Scholar] [CrossRef] [Green Version]
  40. Mao, A.; Zhang, P.; Zhang, K.; Kan, H.; He, D.; Han, X.; Wang, Z.; Tang, C.; Ma, X. Endothelial TRPV4–eNOS coupling as a vital therapy target for treatment of hypertension. Br. J. Pharmacol. 2022, 179, 2297–2312. [Google Scholar] [CrossRef]
  41. Lamb, I.R.; Novielli-Kuntz, N.M.; Murrant, C.L. Capillaries communicate with the arteriolar microvascular network by a pannexin/purinergic-dependent pathway in hamster skeletal muscle. Am. J. Physiol.-Heart Circ. Physiol. 2021, 320, H1699–H1711. [Google Scholar] [CrossRef] [PubMed]
  42. Qian, J.; Fulton, D. Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front. Physiol. 2013, 4, 347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Förstermann, U.; Sessa, W.C. Nitric oxide synthases: Regulation and function. Eur. Heart J. 2012, 33, 829–837. [Google Scholar] [CrossRef] [Green Version]
  44. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R.; Zeiher, A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399, 601–605. [Google Scholar] [CrossRef] [PubMed]
  45. Fleming, I.; Fisslthaler, B.; Dimmeler, S.; Kemp, B.E.; Busse, R. Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 2001, 88, e68–e75. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Hashimoto, A.; Miyakoda, G.; Hirose, Y.; Mori, T. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 2006, 189, 350–357. [Google Scholar] [CrossRef] [PubMed]
  47. Butt, E.; Bernhardt, M.; Smolenski, A.; Kotsonis, P.; Fröhlich, L.G.; Sickmann, A.; Meyer, H.E.; Lohmann, S.M.; Schmidt, H.H.H.W. Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J. Biol. Chem. 2000, 275, 5179–5187. [Google Scholar] [CrossRef] [Green Version]
  48. Jin, Y.J.; Chennupati, R.; Li, R.; Liang, G.; Wang, S.P.; Iring, A.; Graumann, J.; Wettschureck, N.; Offermanns, S. Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation. J. Clin. Investig. 2021, 131, e145734. [Google Scholar] [CrossRef]
  49. Morrow, V.A.; Foufelle, F.; Connell, J.M.C.; Petrie, J.R.; Gould, G.W.; Salt, I.P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 2003, 278, 31629–31639. [Google Scholar] [CrossRef] [Green Version]
  50. Zhang, Y.; Lee, T.S.; Kolb, E.M.; Sun, K.; Lu, X.; Sladek, F.M.; Kassab, G.S.; Garland, T.; Shyy, J.Y.J. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1281–1287. [Google Scholar] [CrossRef] [Green Version]
  51. Ching, L.C.; Chen, C.Y.; Su, K.H.; Hou, H.H.; Shyue, S.K.; Kou, Y.R.U.; Lee, T.S. Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase. Mol. Med. 2012, 18, 805–815. [Google Scholar] [CrossRef] [PubMed]
  52. Su, K.H.; Yu, Y.B.; Hou, H.H.; Zhao, J.F.; Kou, Y.R.; Cheng, L.C.; Shyue, S.K.; Lee, T.S. AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase. J. Cell. Physiol. 2012, 227, 3053–3062. [Google Scholar] [CrossRef] [PubMed]
  53. Michell, B.J.; Brennan Harris, M.; Chen, Z.P.; Ju, H.; Venema, V.J.; Blackstone, M.A.; Huang, W.; Venema, R.C.; Kemp, B.E. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at Serine 617 and Serine 635. J. Biol. Chem. 2002, 277, 42344–42351. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Aulak, K.S.; Barnes, J.W.; Tian, L.; Mellor, N.E.; Haque, M.M.; Willard, B.; Li, L.; Comhair, S.C.; Stuehr, D.J.; Dweik, R.A. Specific O-GlcNAc modification at Ser-615 modulates eNOS function. Redox Biol. 2020, 36, 101625. [Google Scholar] [CrossRef]
  55. Bauer, P.M.; Fulton, D.; Chool Boo, Y.; Sorescu, G.P.; Kemp, B.E.; Jo, H.; Sessa, W.C. Compensatory Phosphorylation and Protein-Protein Interactions Revealed by Loss of Function and Gain of Function Mutants of Multiple Serine Phosphorylation Sites in Endothelial Nitric-oxide Synthase. J. Biol. Chem. 2003, 278, 14841–14849. [Google Scholar] [CrossRef] [Green Version]
  56. Erwin, P.A.; Lin, A.J.; Golan, D.E.; Michel, T. Receptor-regulated Dynamic S-Nitrosylation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells. J. Biol. Chem. 2005, 280, 19888–19894. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Lu, Y.; Xu, Z.; Shen, F.; Lin, R.; Li, H.; Lv, X.; Liu, Z. Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway. Curr. Neurovasc. Res. 2020, 17, 471–479. [Google Scholar] [CrossRef]
  58. Cale, J.M.; Bird, I.M. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner. Biochem. J. 2006, 398, 279–288. [Google Scholar] [CrossRef]
  59. Ramadoss, J.; Pastore, M.B.; Magness, R.R. Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase. Clin. Exp. Pharmacol. Physiol. 2013, 40, 753–764. [Google Scholar] [CrossRef] [Green Version]
  60. Sugimoto, M.; Nakayama, M.; Goto, T.M.; Amano, M.; Komori, K.; Kaibuchi, K. Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem. Biophys. Res. Commun. 2007, 361, 462–467. [Google Scholar] [CrossRef]
  61. Fulton, D.; Church, J.E.; Ruan, L.; Li, C.; Sood, S.G.; Kemp, B.E.; Jennings, I.G.; Venema, R.C. Src Kinase Activates Endothelial Nitric-oxide Synthase by Phosphorylating Tyr-83. J. Biol. Chem. 2005, 280, 35943–35952. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Siragusa, M.; Oliveira Justo, A.F.; Malacarne, P.F.; Strano, A.; Buch, A.; Withers, B.; Peters, K.G.; Fleming, I. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes. Cardiovasc. Res. 2021, 117, 1546–1556. [Google Scholar] [CrossRef] [PubMed]
  63. Loot, A.E.; Schreiber, J.G.; Fisslthaler, B.; Fleming, I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J. Exp. Med. 2009, 206, 2889–2896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Fisslthaler, B.; Loot, A.E.; Mohamed, A.; Busse, R.; Fleming, I. Inhibition of Endothelial Nitric Oxide Synthase activity by Proline-Rich Tyrosine Kinase 2 in response to fluid shear stress and insulin. Circ. Res. 2008, 102, 1520–1528. [Google Scholar] [CrossRef] [PubMed]
  65. Daiber, A.; Xia, N.; Steven, S.; Oelze, M.; Hanf, A.; Kröller-Schön, S.; Münzel, T.; Li, H. New therapeutic implications of endothelial nitric oxide synthase (eNOS) function/dysfunction in cardiovascular disease. Int. J. Mol. Sci. 2019, 20, 187, ISBN 6131176280. [Google Scholar] [CrossRef] [Green Version]
  66. Baümer, S.; Keller, L.; Holtmann, A.; Funke, R.; August, B.; Gamp, A.; Wolburg, H.; Wolburg-Buchholz, K.; Deutsch, U.; Vestweber, D. Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006, 107, 4754–4762. [Google Scholar] [CrossRef] [Green Version]
  67. Justo, A.F.O.; Afonso, P.P.L. The role of vascular endothelial protein tyrosine phosphatase on nitric oxide synthase function in diabetes: From molecular biology to the clinic. J. Cell Commun. Signal. 2021, 15, 467–471. [Google Scholar] [CrossRef]
  68. Schmid, J.; Müller, B.; Heppeler, D.; Gaynullina, D.; Kassmann, M.; Gagov, H.; Mladenov, M.; Gollasch, M.; Schubert, R. The unexpected role of calcium-activated potassium channels: Limitation of no-induced arterial relaxation. J. Am. Heart Assoc. 2018, 7, e007808. [Google Scholar] [CrossRef]
  69. Gagov, H.; Gribkova, I.; Serebryakov, V.; Schubert, R. Sodium Nitroprusside-Induced Activation of Vascular Smooth Muscle BK Channels Is Mediated by PKG Rather Than by a Direct Interaction with NO. Int. J. Mol. Sci. 2022, 23, 2798. [Google Scholar] [CrossRef]
  70. Kyle, B.D.; Hurst, S.; Swayze, R.D.; Sheng, J.; Braun, A.P. Specific phosphorylation sites underlie the stimulation of a large conductance, Ca2+-activated K+ channel by cGMP-dependent protein kinase. FASEB J. 2013, 27, 2027–2038. [Google Scholar] [CrossRef]
  71. Tykocki, N.R.; Boerman, E.M.; Jackson, W.F. Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Compr. Physiol. 2017, 7, 485–581. [Google Scholar] [CrossRef] [Green Version]
  72. Schlossmann, J.; Desch, M. IRAG and novel PKG targeting in the cardiovascular system. Am. J. Physiol.-Hear. Circ. Physiol. 2011, 301, H672–H682. [Google Scholar] [CrossRef] [Green Version]
  73. Nakamura, K.; Koga, Y.; Sakai, H.; Homma, K.; Ikebe, M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ. Res. 2007, 101, 712–722. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Capellini, V.K.; Restini, C.B.A.; Bendhack, L.M.; Evora, P.R.B.; Celotto, A.C. The Effect of Extracellular pH Changes on Intracellular pH and Nitric Oxide Concentration in Endothelial and Smooth Muscle Cells from Rat Aorta. PLoS ONE 2013, 8, e62887. [Google Scholar] [CrossRef] [PubMed]
  75. Hattori, K.; Tsuchida, S.; Tsukahara, H.; Mayumi, M.; Tanaka, T.; Zhang, L.; Taniguchi, T.; Muramatsu, I. Augmentation of NO-mediated vasodilation in metabolic acidosis. Life Sci. 2002, 71, 1439–1447. [Google Scholar] [CrossRef]
  76. Celotto, A.C.; Ferreira, L.G.; Capellini, V.K.; Albuquerque, A.A.S.; Rodrigues, A.J.; Evora, P.R.B. Acute but not chronic metabolic acidosis potentiates the acetylcholine-induced reduction in blood pressure: An endothelium-dependent effect. Braz. J. Med. Biol. Res. 2016, 49, e5007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Heintz, A.; Damm, M.; Brand, M.; Koch, T.; Deussen, A. Coronary flow regulation in mouse heart during hypercapnic acidosis: Role of NO and its compensation during eNOS impairment. Cardiovasc. Res. 2008, 77, 188–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Gurevicius, J.; Salem, M.R.; Metwally, A.A.; Silver, J.M.; Crystal, G.J. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis. Am. J. Physiol. 1995, 268, H39–H47. [Google Scholar] [CrossRef]
  79. Wang, Q.; Paulson, O.B.; Lassen, N.A. Effect of nitric oxide blockade by NG-nitro-l-arginine on cerebral blood flow response to changes in carbon dioxide tension. J. Cereb. Blood Flow Metab. 1992, 12, 947–953. [Google Scholar] [CrossRef] [Green Version]
  80. Niwa, K.; Lindauer, U.; Villringer, A.; Dirnagl, U. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular acidosis. J. Cereb. Blood Flow Metab. 1993, 13, 535–539. [Google Scholar] [CrossRef] [Green Version]
  81. You, J.P.; Wang, Q.; Zhang, W.; Jansen-Olesen, I.; Paulson, O.B.; Lassen, N.A.; Edvinsson, L. Hypercapnic vasodilatation in isolated rat basilar arteries is exerted via low pH and does not involve nitric oxide synthase stimulation or cyclic GMP production. Acta Physiol. Scand. 1994, 152, 391–397. [Google Scholar] [CrossRef] [PubMed]
  82. Toda, N.; Ayajiki, K.; Okamura, T. Hypercapnia relaxes cerebral arteries and potentiates neurally-induced relaxation. J. Cereb. Blood Flow Metab. 1996, 16, 1068–1074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Schmetterer, L.; Findl, O.; Strenn, K.; Graselli, U.; Kastner, J.; Eichler, H.G.; Wolzt, M. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 1997, 273, R2005–R2012. [Google Scholar] [CrossRef] [PubMed]
  84. Najarian, T.; Marrache, A.M.; Dumont, I.; Hardy, P.; Beauchamp, M.H.; Hou, X.; Peri, K.; Gobeil, F.; Varma, D.R.; Chemtob, S. Prolonged hypercapnia-evoked cerebral hyperemia via K+ channel- and prostaglandin E2-dependent endothelial nitric oxide synthase induction. Circ. Res. 2000, 87, 1149–1156. [Google Scholar] [CrossRef] [Green Version]
  85. Checchin, D.; Hou, X.; Hardy, P.; Abran, D.; Najarian, T.; Beauchamp, M.H.; Bernier, S.G.; Gobeil, F.; Quiniou, C. PGE2-Mediated eNOS Induction in Prolonged Hypercapnia. Investig. Ophthalmol. Vis. Sci. 2002, 43, 1558–1566. [Google Scholar]
  86. Haque, I.U.; Huang, C.J.; Scumpia, P.O.; Nasiroglu, O.; Skimming, J.W. Intravascular infusion of acid promotes intrapulmonary inducible nitric oxide synthase activity and impairs blood oxygenation in rats. Crit. Care Med. 2003, 31, 1454–1460. [Google Scholar] [CrossRef]
  87. Mizuno, S.; Demura, Y.; Ameshima, S.; Okamura, S.; Miyamori, I.; Ishizaki, T. Alkalosis stimulates endothelial nitric oxide synthase in cultured human pulmonary arterial endothelial cells. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2002, 283, 113–119. [Google Scholar] [CrossRef]
  88. Giraldez, R.R.; Panda, A.; Xia, Y.; Sanders, S.P.; Zweier, J.L. Decreased nitric-oxide synthase activity causes impaired endothelium- dependent relaxation in the postischemic heart. J. Biol. Chem. 1997, 272, 21420–21426. [Google Scholar] [CrossRef] [Green Version]
  89. Ziegelstein, R.C.; Cheng, L.; Blank, P.S.; Spurgeon, H.A.; Lakatta, E.G.; Hansford, R.G.; Capogrossi, M.C. Modulation of calcium homeostasis in cultured rat aortic endothelial cells by intracellular acidification. Am. J. Physiol. -Heart Circ. Physiol. 1993, 265, H1424–H1433. [Google Scholar] [CrossRef]
  90. Nishio, K.; Suzuki, Y.; Takeshita, K.; Aoki, T.; Kudo, H.; Sato, N.; Naoki, K.; Miyao, N.; Ishii, M.; Yamaguchi, K. Effects of hypercapnia and hypocapnia on [Ca2+]i mobilization in human pulmonary artery endothelial cells. J. Appl. Physiol. 2001, 90, 2094–2100. [Google Scholar] [CrossRef] [Green Version]
  91. Sasahara, T.; Yayama, K.; Matsuzaki, T.; Tsutsui, M.; Okamoto, H. Na +/H + exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2+ mobilization. Vascul. Pharmacol. 2013, 58, 319–325. [Google Scholar] [CrossRef]
  92. Köhler, R.; Heyken, W.T.; Heinau, P.; Schubert, R.; Si, H.; Kacik, M.; Busch, C.; Grgic, I.; Maier, T.; Hoyer, J. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1495–1502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Mendoza, S.A.; Fang, J.; Gutterman, D.D.; Wilcox, D.A.; Bubolz, A.H.; Li, R.; Suzuki, M.; Zhang, D.X. TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am. J. Physiol.-Heart Circ. Physiol. 2010, 298, H466–H476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Suzuki, M.; Mizuno, A.; Kodaira, K.; Imai, M. Impaired pressure sensation in mice lacking TRPV4. J. Biol. Chem. 2003, 278, 22664–22668. [Google Scholar] [CrossRef] [Green Version]
  95. Wang, Q.; Wu, G.; Reznikov, L.; Zhou, G.; Zha, X.-M. GPR68 Contributes to Persistent Acidosis-Induced Activation of AGC Kinases and Tyrosine Phosphorylation in Organotypic Hippocampal Slices. Front. Neurosci. 2021, 1, 692217. [Google Scholar] [CrossRef]
  96. Qiao, X.; Xu, J.; Yang, Q.J.; Du, Y.; Lei, S.; Liu, Z.H.; Liu, X.; Liu, H. Transient acidosis during early reperfusion attenuates myocardium ischemia reperfusion injury VIA PI3K-AKT-enos signaling pathway. Oxid. Med. Cell. Longev. 2013, 2013, 126083. [Google Scholar] [CrossRef]
  97. Epler, M.J.; Souba, W.W.; Meng, Q.H.; Lin, C.M.; Karinch, A.M.; Vary, T.C.; Pan, M. Metabolic acidosis stimulates intestinal Glutamine absorption. J. Gastrointest. Surg. 2003, 7, 1045–1052. [Google Scholar] [CrossRef]
  98. Pahlavan, P.; Wang, L.J.; Sack, E.; Arruda, J.A. Role of protein kinase C in the adaptive increase in Na-H antiporter in respiratory acidosis. J. Am. Soc. Nephrol. 1993, 4, 1079–1086. [Google Scholar] [CrossRef]
  99. Mochalov, S.V.; Tarasova, N.V.; Kudryashova, T.V.; Gaynullina, D.K.; Kalenchuk, V.U.; Borovik, A.S.; Vorotnikov, A.V.; Tarasova, O.S.; Schubert, R. Higher Ca2+-sensitivity of arterial contraction in 1-week-old rats is due to a greater Rho-kinase activity. Acta Physiol. 2018, 223, e13044. [Google Scholar] [CrossRef]
  100. Kent, A.L.; Kecskes, Z.; Shadbolt, B.; Falk, M.C. Blood pressure in the first year of life in healthy infants born at term. Pediatr. Nephrol. 2007, 22, 1743–1749. [Google Scholar] [CrossRef]
  101. Stulcova, B. Postnatal development of cardiac output distribution measured by radioactive microspheres in rats. Neonatology 1977, 32, 119–124. [Google Scholar] [CrossRef]
  102. Nankervis, C.A.; Reber, K.M.; Nowicki, P.T. Age-dependent changes in the postnatal intestinal microcirculation. Microcirculation 2001, 8, 377–387. [Google Scholar] [CrossRef] [PubMed]
  103. Nankervis, C.A.; Nowicki, P.T. Role of nitric oxide in regulation of vascular resistance in postnatal intestine. Am. J. Physiol. 1995, 268, 949–958. [Google Scholar] [CrossRef] [PubMed]
  104. Sofronova, S.I.; Borzykh, A.A.; Gaynullina, D.K.; Kuzmin, I.V.; Shvetsova, A.A.; Lukoshkova, E.V.; Tarasova, O.S. Endothelial nitric oxide weakens arterial contractile responses and reduces blood pressure during early postnatal development in rats. Nitric Oxide-Biol. Chem. 2016, 55–56, 1–9. [Google Scholar] [CrossRef] [PubMed]
  105. Gaynullina, D.; Lubomirov, L.T.; Sofronova, S.I.; Kalenchuk, V.U.; Gloe, T.; Pfitzer, G.; Tarasova, O.S.; Schubert, R. Functional remodelling of arterial endothelium during early postnatal development in rats. Cardiovasc. Res. 2013, 99, 612–621. [Google Scholar] [CrossRef] [PubMed]
  106. Reber, K.M.; Su, B.Y.; Reed Clark, K.; Pohlman, D.L.; Miller, C.E.; Nowicki, P.T. Developmental expression of eNOS in postnatal swine mesenteric artery. Am. J. Physiol.-Gastrointest. Liver Physiol. 2002, 283, G1328–G1335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Chatrath, R.; Ronningen, K.L.; Severson, S.R.; LaBreche, P.; Jayachandran, M.; Bracamonte, M.P.; Miller, V.M. Endothelium-dependent responses in coronary arteries are changed with puberty in male pigs. Am. J. Physiol.-Heart Circ. Physiol. 2003, 285, H1168–H1176. [Google Scholar] [CrossRef] [Green Version]
  108. Remzső, G.; Németh, J.; Varga, V.; Kovács, V.; Tóth-Szűki, V.; Kaila, K.; Voipio, J.; Domoki, F. Brain interstitial pH changes in the subacute phase of hypoxic-ischemic encephalopathy in newborn pigs. PLoS ONE 2020, 15, e0233851. [Google Scholar] [CrossRef]
  109. Workineh, Y.; Semachew, A.; Ayalew, E.; Animaw, W.; Tirfie, M.; Birhanu, M. Prevalence of perinatal asphyxia in East and Central Africa: Systematic review and meta-analysis. Heliyon 2017, 6, e03793. [Google Scholar] [CrossRef]
  110. Lawn, J.E.; Manandhar, A.; Haws, R.A.; Darmstadt, G.L. Reducing one million child deaths from birth asphyxia-a survey of health systems gaps and priorities. Health Res. Policy Syst. 2007, 5, 4. [Google Scholar] [CrossRef] [Green Version]
  111. Moshiro, R.; Mdoe, P.; Perlman, J.M. A Global View of Neonatal Asphyxia and Resuscitation. Front. Pediatr. 2019, 7, 489. [Google Scholar] [CrossRef] [Green Version]
  112. Nakanishi, T.; Gu, H.; Momma, K. Effect of acidosis on contraction, intracellular pH, and calcium in the newborn and adult rabbit aorta. Heart Vessels 1997, 12, 207–215. [Google Scholar] [CrossRef] [PubMed]
  113. Nakanishi, T.; Gu, H.; Momma, K. Developmental changes in the effect of acidosis on contraction, intracellular pH, and calcium in the rabbit mesenteric small artery. Pediatr. Res. 1997, 42, 750–757. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Reddy, M.K.; Patel, K.P.; Schultz, H.D. Differential role of the paraventricular nucleus of the hypothalamus in modulating the sympathoexcitatory component of peripheral and central chemoreflexes. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2005, 289, 789–797. [Google Scholar] [CrossRef] [PubMed]
  115. Wenker, I.C.; Abe, C.; Viar, K.E.; Stornetta, D.S.; Stornetta, R.L.; Guyenet, P.G. Blood Pressure Regulation by the Rostral Ventrolateral Medulla in Conscious Rats: Effects of Hypoxia, Hypercapnia, Baroreceptor Denervation, and Anesthesia. J. Neurosci. 2017, 37, 4565–4583. [Google Scholar] [CrossRef] [Green Version]
  116. Todd, M.E. Development of adrenergic innervation in rat peripheral vessels: A fluorescence microscopic study. J. Anat. 1980, 131, 121–133. [Google Scholar]
  117. Puzdrova, V.A.; Kudryashova, T.V.; Gaynullina, D.K.; Mochalov, S.V.; Aalkjaer, C.; Nilsson, H.; Vorotnikov, A.V.; Schubert, R.; Tarasova, O.S. Trophic action of sympathetic nerves reduces arterial smooth muscle Ca2+ sensitivity during early post-natal development in rats. Acta Physiol. 2014, 212, 128–141. [Google Scholar] [CrossRef]
  118. Mulvany, M.J.; Halpern, W. Contractile Properties of Small Arterial Resistance Vessels in Spontaneously Hypertensive and Normotensive Rats. Circ. Res. 1977, 41, 19–26. [Google Scholar] [CrossRef] [Green Version]
Ijms 23 05987 g001 550
Figure 1. Acidosis potentiates the functional contribution of eNOS to the regulation of vascular tone in the early postnatal period. In 10–15-day old rat pups, extracellular acidosis (pH 6.8) reduces contractile responses of saphenous arteries to the α1-adrenoceptor agonist methoxamine by increasing the anticontractile influence of NO. (a) Concentration-response relationships to methoxamine in the presence of the NO-synthase inhibitor L-NNA (100 µM) or its vehicle (H2O, 50 µL) at pH 7.4 and pH 6.8. The numbers in brackets indicate the number of animals. * p < 0.05 (two-way ANOVA with Tukey’s multiple comparisons test). (b) Contractile effect of L-NNA at pH 7.4 and pH 6.8. # p < 0.05 (unpaired Student’s t-test).
Figure 1. Acidosis potentiates the functional contribution of eNOS to the regulation of vascular tone in the early postnatal period. In 10–15-day old rat pups, extracellular acidosis (pH 6.8) reduces contractile responses of saphenous arteries to the α1-adrenoceptor agonist methoxamine by increasing the anticontractile influence of NO. (a) Concentration-response relationships to methoxamine in the presence of the NO-synthase inhibitor L-NNA (100 µM) or its vehicle (H2O, 50 µL) at pH 7.4 and pH 6.8. The numbers in brackets indicate the number of animals. * p < 0.05 (two-way ANOVA with Tukey’s multiple comparisons test). (b) Contractile effect of L-NNA at pH 7.4 and pH 6.8. # p < 0.05 (unpaired Student’s t-test).
Ijms 23 05987 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gaynullina, D.K.; Tarasova, O.S.; Shvetsova, A.A.; Borzykh, A.A.; Schubert, R. The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis. Int. J. Mol. Sci. 2022, 23, 5987. https://doi.org/10.3390/ijms23115987

AMA Style

Gaynullina DK, Tarasova OS, Shvetsova AA, Borzykh AA, Schubert R. The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis. International Journal of Molecular Sciences. 2022; 23(11):5987. https://doi.org/10.3390/ijms23115987

Chicago/Turabian Style

Gaynullina, Dina K., Olga S. Tarasova, Anastasia A. Shvetsova, Anna A. Borzykh, and Rudolf Schubert. 2022. "The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis" International Journal of Molecular Sciences 23, no. 11: 5987. https://doi.org/10.3390/ijms23115987

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop